Effectiveness and safety of subcutaneous infliximab in perianal Crohn's disease: a multicentre cohort study

被引:0
|
作者
Andre, M. [1 ]
Kirchgesner, J. [2 ]
Laharie, D. [3 ]
Guillo, L. [4 ]
Abramowitz, L. [5 ]
Seksik, P. [6 ]
Nachury, M. [7 ]
Fumery, M. [8 ]
Amil, M. [9 ]
Nancey, S. [10 ]
Le Berre, C. [11 ]
Moussata, D. [12 ]
Buisson, A. [13 ]
Fathallah, N. [14 ]
Gilletta, C. [15 ]
Uzzan, M. [16 ]
Duveau, N. [17 ]
Peyrin-Biroulet, L. [18 ]
Nahon, S. [19 ]
Savoye, G. [20 ]
Charkaoui, M. [21 ]
Vicaut, E. [22 ]
Vuitton, L. [1 ]
机构
[1] CHU Besancon, Dept Gastroenterol, Besancon, France
[2] APHP St Antoine, Gastroenterol, Paris, France
[3] CHU Bordeaux, Hepatogastroenterol, Bordeaux, France
[4] Hop Nord Marseille, APHM, Dept Gastroenterol, Marseille, France
[5] Hop Bichat Claude Bernard, AP HP, Dept Gastroenterol, Paris, France
[6] Hop St Antoine, AP HP, Dept Gastroenterol, Paris, France
[7] CHU Lille, Hepatogastroenterol, Lille, France
[8] CHU Amiens, Hepatogastroenterl, Amiens, France
[9] CH Vendee, Dept Gastroenterol, La Roche Sur Yon, France
[10] CHU Lyon Sud, Dept Gastroenterol, Lyon, France
[11] CHU Nantes, Dept Gastroenterol, Nantes, France
[12] CHU Tours, Dept Gastroenterol, Tours, France
[13] CHU Clermont Ferrand, Dept Gastroenterol, Clermont Ferrand, France
[14] Hop St Joseph, Dept Gastroenterol, Paris, France
[15] CHU Toulouse, Dept Gastroenterol, Toulouse, France
[16] Hop Mondor, AP HP, Dept Gastroenterol, Creteil, France
[17] CH Roubaix, Dept Gastroenterol, Roubaix, France
[18] CHU Nancy, Dept Gastroenterol, Nancy, France
[19] CH Montfermeil, Dept Gastroenterol, Montfermeil, France
[20] CH Rouen, Dept Gastroenterol, Rouen, France
[21] CHU Dijon, Dept Gastroenterol, Dijon, France
[22] AP HP, Methodol, Paris, France
来源
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P857
引用
收藏
页码:I1577 / I1577
页数:1
相关论文
共 50 条
  • [41] Local injection of infliximab in severe fistulating perianal Crohn's disease: an open uncontrolled study
    Alessandroni, L.
    Kohn, A.
    Cosintino, R.
    Marrollo, M.
    Papi, C.
    Monterubbianesi, R.
    Tersigni, R.
    [J]. TECHNIQUES IN COLOPROCTOLOGY, 2011, 15 (04) : 407 - 412
  • [42] Local injection of infliximab in severe fistulating perianal Crohn’s disease: an open uncontrolled study
    L. Alessandroni
    A. Kohn
    R. Cosintino
    M. Marrollo
    C. Papi
    R. Monterubbianesi
    R. Tersigni
    [J]. Techniques in Coloproctology, 2011, 15 : 407 - 412
  • [43] Evaluation of effectiveness of infliximab in the treatment of perianal form of Crohn's disease in a 16-year old girl
    Mierzwa, Grazyna
    Czerwionka-Szaflarska, Mieczyslawa
    Kuczynska, Renata
    [J]. PRZEGLAD GASTROENTEROLOGICZNY, 2008, 3 (03): : 161 - 164
  • [44] Multicentre cohort study to evaluate the need for re-intervention following multimodal treatment in Crohn's disease with perianal fistula
    Sebastian, S.
    Black, C.
    Pugliese, D.
    Armuzzi, A.
    Sahnan, K.
    Elkady, S. M.
    Katsanos, K. H.
    Christodoulou, D. K.
    Selinger, C.
    Maconi, G.
    Fiorino, G.
    Kopylov, U.
    Davidov, Y.
    Bosca-Watts, M. M.
    Ellul, P.
    Muscat, M.
    Karmiris, K.
    Fearnhead, N. S.
    Allgar, V.
    Hart, A. L.
    Ben-Horin, S.
    Danese, S.
    [J]. JOURNAL OF CROHNS & COLITIS, 2017, 11 : S330 - S330
  • [45] Infliximab and newly diagnosed neoplasia in Crohn's disease: a multicentre matched pair study
    Biancone, L
    Orlando, A
    Kohn, A
    Colombo, E
    Sostegni, R
    Angelucci, E
    Rizzello, F
    Castiglione, F
    Benazzato, L
    Papi, C
    Meucci, G
    Riegler, G
    Petruzziello, C
    Mocciaro, F
    Geremia, A
    Calabrese, E
    Cottone, M
    Pallone, F
    [J]. GUT, 2006, 55 (02) : 228 - 233
  • [46] Comparative Effectiveness of Infliximab and Adalimumab for Crohn's Disease
    Haynes, Kevin
    Osterman, Mark T.
    Delzell, Elizabeth
    Zhang, Jie
    Bewtra, Meenakshi
    Brensinger, Colleen
    Chen, Lang
    Xie, Fenlong
    Curtis, Jeffrey R.
    Lewis, James D.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 359 - 359
  • [47] Comparative Effectiveness of Infliximab and Adalimumab for Crohn's Disease
    Osterman, Mark T.
    Haynes, Kevin
    Delzell, Elizabeth
    Zhang, Jie
    Bewtra, Meenakshi
    Brensinger, Colleen
    Chen, Lang
    Xie, Fenlong
    Curtis, Jeffrey R.
    Lewis, James D.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2014, 12 (05) : 811 - U137
  • [48] Estimating the cost effectiveness of infliximab for Crohn's disease
    Wong, JB
    Loftus, EV
    Sandborn, WJ
    Feagan, BG
    [J]. GASTROENTEROLOGY, 1999, 116 (04) : A104 - A105
  • [49] The cost-effectiveness of infliximab in Crohn's disease
    Smart, Claire
    Selinger, Christian P.
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2014, 14 (05) : 589 - 598
  • [50] Effectiveness and safety of darvadstrocel in patients with complex perianal fistulizing Crohn's disease: a systematic review
    Fousekis, Fotios S.
    Mpakogiannis, Konstantinos
    Lianos, Georgios D.
    Koukoudis, Anastasios
    Christodoulou, Dimitrios K.
    Papaconstantinou, Ioannis
    Katsanos, Konstantinos H.
    [J]. ANNALS OF GASTROENTEROLOGY, 2024, 37 (01): : 46 - 53